Plants respond to infection by microbial pathogens, and express defense responses, including preexisting antimicrobial compounds, phytoanticipins, and de novo production of antimicrobial compounds, phytoalexins ([@ref16]; [@ref25]). In order to establish infection, phytopathogens need to eliminate the effects of these antimicrobial compounds to convert the antimicrobials to ineffective structures by enzymes, to convert the structure of target proteins to those not affected by antimicrobial substances, and to extrude antimicrobials outside the cell. To extrude antimicrobials, bacteria have five structural groups of multidrug resistance (MDR) efflux pump transporters: resistance-nodulation-cell division (RND), small multidrug resistance, multi-antimicrobial extrusion, the major facilitator superfamily, and ATP-binding cassette superfamilies (Hernando-Amado et al., 2016; [@ref13]).

Some of the most relevant roles of RND efflux pumps so far identified include bacterial virulence, plant-bacteria interactions, transport of quorum sensing molecules, and extrusion of various kinds of toxic compounds ([@ref1]; [@ref2]). The RND efflux pump is a tripartite complex composed of an inner membrane protein (IMP), an outer membrane protein (OMP), and a periplasmic membrane-fusion protein (MFP). The genes encoding each subunit are usually found in a single operon. In *Pseudomonas syringae*, there are different operons for the RND efflux pump transporter, *mexAB*-*oprM* and *mexEF*-*oprN*. The *mexA* and *mexE* encode MFP, whereas *mexB* and *mexF* encode IMP, and *oprM* and *oprN* encode OMP. We previously investigated the gene expression profiles in *P*. *syringae* pv. *tabaci* 6605 (*Pta* 6605) wild-type (WT) and its mutant strains by microarray analysis ([@ref22]), and found that *mexAB-oprM* is constitutively expressed, whereas *mexEF*-*oprN* is hardly expressed in the WT strain. However, these expressions were sometimes dramatically changed in the mutant strains. A ﬂagellin-defective mutant ∆*ﬂiC*, a flagellin-glycosylation-defective mutant ∆*fgt1*, and an *N*-acyl-homoserine lactone (AHL) synthase-defective mutant ∆*psyI* were incapable of synthesizing AHL and upregulating *mexEF*-*oprN* expression ([@ref17]; [@ref22]). On the other hand, ∆*vfr*, a mutant of the virulence factor regulator, and ∆*pilA*, a mutant of pilin protein in type 4 pili upregulated the expression of *mexAB*-*oprM* ([@ref20], [@ref21]). These results provided an insight: flagella-mediated and pili-mediated motility-defective mutants have to adapt to a given condition and change their gene expression profile, including *mexAB*-*oprM* and *mexEF*-*oprN*, for survival ([@ref17]; [@ref20]; [@ref22]). Thus, the expressions of MDR efflux pump-related genes are responsive to environmental and genetic changes.

The mutant strains of ∆*mexAB*-*oprM* of *P*. *syringae* pv. *phaseolicola* 1448A, pv. *syringae* B728a, and pv. *tomato* DC3000 had reduced populations after inoculation into their own host leaves, indicating that MexAB-OprM contributes to virulence ([@ref19]). The susceptibilities of these mutants to aminoglycosides, β-lactams, chloramphenicol, ethidium bromide, fluoroquinolones, macrolides, nitrofurantoin, quinolones, rifampin, and tetracycline were increased, indicating that these compounds are potential substrates of MexAB-OprM ([@ref6]; [@ref19]). Characterization of an RND transporter system in *P*. *syringae* pv. *syringae* B301D, the PseABC efflux system, revealed that PseABC has an important role in secretion of syringomycin and syringopeptin, phytotoxins of this pathogen ([@ref12]). However, the role of RND efflux pumps in the secretion of the plant antimicrobial metabolites is not clear yet. In this study, we generated two single mutants for two major RND efflux pumps, ∆*mexB* and ∆*mexF*, and a double mutant, ∆*mexB*∆*mexF*, and investigated the growth inhibition effect of plant-derived antimicrobials, such as phytoanticipins and phytoalexins. Furthermore, the effects of the mutation on the expression of these RND pump genes, motility, and virulence were characterized. The roles of MexAB-OprM and MexEF-OprN in bacterial virulence are discussed.

Materials and Methods
=====================

Bacterial strains and growth conditions
---------------------------------------

All bacterial strains used in this study are listed in [Table 1](#T1){ref-type="table"}. *Pta* 6605 strains, *Escherichia coli* strains, and *Chromobacterium violaceum* CV026 were grown as described previously ([@ref10]).

Generation of ∆*mexB* and ∆*mexB*∆*mexF* mutants in *Pta* 6605.
---------------------------------------------------------------

An approximately 5.8 kb DNA fragment encoding *mexAB-oprM* was amplified with a set of primers, mexA5 and oprM3, using KOD FX DNA polymerase (Toyobo, Osaka, Japan) with the genomic DNA of *Pta* 6605 as a template, then introduced into a pCR-Blunt II-TOPO plasmid vector (Invitrogen, Carlsbad, CA, USA) to obtain pCR-*mexAB-oprM* ([Fig. 1A](#F1){ref-type="fig"}). To delete the *mexB* region from the plasmid, inverse PCR was carried out with a set of primers, mexB-d5NheI and mexB-d3NheI, and self-ligated by a Ligation-Convenience kit (Nippon Gene, Tokyo, Japan) after *Nhe*I and *Dpn*I digestions. The mutated genetic region was introduced into pK18*mobsacB* ([@ref18]) via an *Eco*RI site to generate pK18-∆*mexB*, then introduced into *E*. *coli* S17-1 for conjugation with *Pta* 6605 strains. Deletion mutants were obtained by conjugation and homologous recombination according to the previously reported methods ([@ref23]). The DNA sequence of the mutated region in the bacterium was confirmed by DNA sequencing with a Big Dye terminator cycle sequencing kit and an ABI PRISM 3100 sequencer (Thermo Fisher Scientific, Waltham, MA, USA). Primer sequences were designed based on the sequence of *Pta* 6605 provided by Dr. Studholme, University of Exeter, UK.

Using a previously generated ∆*mexF* mutant (Sawada et al., 2018) as a recipient, *mexB* was deleted by a conjugation and homologous recombination as described above, and the ∆*mexB*∆*mexF* double mutant was generated.

*In vitro* growth assay
-----------------------

An overnight culture was centrifuged at 1,500 ×*g* for 5 min at 4°C, the bacterial pellet was resuspended in LB medium with 10 mM MgCl~2~, and the OD~660~ was adjusted to 0.02. Three ml of the bacterial culture was incubated at 27°C with shaking, and the bacterial OD~660~ was measured with an OD meter at each time point.

Potential plant antibiotics
---------------------------

Potential antibiotics, trans-cinnamic acid, naringenin, acetovanillone, (+)-catechin, catechol, scopoletin, and coumarin were obtained from Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan), phloretin, chlorogenic acid, and *p*-coumaric acid were obtained from Sigma-Aldrich (St. Louis, MO, USA), and acetosyringone was obtained from Cayman Chemical (Ann Arbor, MI, USA). Phytoalexins, capsidiol, debneyol, and rishitin were purified in the plant pathology laboratory of Nagoya University.

Growth inhibition zone
----------------------

Potential antibiotics and antibiotics were dissolved in sterilized and distilled water or dimethyl sulfoxide. Bacteria (3 ml) cultured overnight in King's B (KB) medium were mixed with 50 ml of melted 0.6% agar KB medium, then poured into three Petri dishes.

Compound-absorbed paper discs were put on the Petri dish, and the dishes were incubated at 27°C. After 24 h incubation, the growth inhibition zone was photographed and measured using Adobe Photoshop CC version 19.1.9 (Adobe, San Jose, CA, USA). The photographic data was gray-scaled, then noise was removed with a high-pass filter to a middle value of brightness, the image was converted into two gradations, and the growth inhibition zone was measured.

Extraction of total RNA and quantitative reverse transcription PCR (qRT-PCR)
----------------------------------------------------------------------------

Overnight cultured bacteria were harvested by centrifugation and further incubated in MMMF medium (50 mM potassium phosphate buffer, 7.6 mM (NH4)2SO4, 1.7 mM MgCl~2~, and 1.7 mM NaCl, pH 5.7, supplemented with 10 mM each of mannitol and fructose) for an additional 1 h.

Total RNA was extracted from the cells collected by centrifugation using Trizol (Thermo Fisher Scientific). For qRT-PCR, the cDNA was synthesized using 0.5 µg of total RNA and ReverTra Ace qPCR RT Master Mix with gDNA Remover (Toyobo) according to the manufacturer's instructions. The speciﬁc primer sets for *mexA* (mexA-F1 and mexA-R1), *mexE* (mexE-F1 and mexE-R1), and *pcaG* (pcaG-F and pcaG-R) were designed according to the registered sequences of *Pta* 6605 ([Table 2](#T2){ref-type="table"}). Real-time qRT-PCR was carried out using a GVP-9600 (Shimadzu, Kyoto, Japan) and KAPA SYBR FAST qPCR Master Mix (2×) Kit (Sigma-Aldrich), with primers at a final concentration of 0.4 µM each and 1 µl of cDNA product as a template in a 20 µl reaction mixture. PCR was performed with one denaturation cycle of 20 s at 95°C and 40 cycles of 15 s at 95°C and 30 s at 62°C. The expression of each gene was normalized by *pcaG*, which encodes protocatechuate 3,4-dioxygenase subunit alpha, as a stably expressed gene ([@ref22]). Melting curve analysis confirmed that each PCR was a single product. The PCRs were performed with a high linearity. The data were analyzed using the ∆∆*C*T (cycle threshold) method.

Virulence test
--------------

An inoculation test of *Pta* 6605 was conducted with a flood assay ([@ref11]) optimized for tobacco plants (*Nicotiana tabacum* L. cv. Xanthi). Tobacco seeds were sterilized and sown on 0.8% Murashige-Skoog (MS) agar plates containing 1% sucrose and vitamin stock solution (thiamin hydrochloride 3 mg/l, nicotinic acid 5 mg/l, pyridoxine hydrochloride 0.5 mg/l), and grown at 28°C under 16 h light:8 h dark conditions for 2 weeks. Tobacco seedlings were transplanted to 0.8% MS agar plates containing 0.1% sucrose and vitamin stock solution as above and grown for 2 days under the same conditions. Bacteria were grown overnight at 27°C in KB medium with 50 μg/ml of nalidixic acid (Nal). The bacterial inoculum was adjusted to OD~600~ = 0.002 with sterilized water containing 0.025% Silwet L-77 (Biomedical Sciences, Tokyo, Japan). Sterilized water containing 0.025% Silwet L-77 was used as a mock treatment. The inoculation test was carried out on a clean bench. The bacterial suspension (approximately 30 ml) was poured into the plate of tobacco seedlings. After about 10 s incubation, the bacterial suspension was decanted, and the plate was air-dried on a clean bench for 15 min. The plants were incubated under 16 h light:8 h dark conditions at 22°C, and disease symptoms were observed for 4 days post-inoculation (dpi) and 10 dpi. To determine the bacterial population at 0 dpi and 4 dpi, leaf disks were punched out using a disposable biopsy hole punch and then ground with mortar and pestle. The homogenates were serially diluted in sterile distilled water and then spread on KB plates containing Nal. The plates were dried and incubated at 27°C for 2 days, after which the bacterial population

was measured by counting the number of colonies (colony forming unit).

Swimming and swarming motilities
--------------------------------

Swimming and swarming assays were performed as described previously ([@ref20]). An overnight culture with 50 µg/ml of Nal was centrifuged at 1,500 ×*g* for 10 min, the bacterial pellet was resuspended in 10 mM MgSO~4~, and the OD~660~ was adjusted to 1.0. For the swimming assay, 3 μl of bacterial suspension was inoculated on the center of 0.25% Bactoagar (Becton Dickinson & Company, Glencoe, MD, USA) (w/v) MMMF plates. For the swarming assay, 3 μl of the bacterial suspension was spotted on the center of a 0.45% Bactoagar (w/v) SWM (0.5% peptone and 0.3% yeast extract) plate and allowed to dry. Plates were incubated overnight at 23°C. Swimming and swarming motilities were observed after 24 h incubations.

Detection of *N*-acyl homoserine lactones
-----------------------------------------

Bacterial strains were grown in KB medium for 24 h at 27°C. AHLs were extracted with an equal volume of ethyl acetate and detected using C~18~ reversed-phase thin layer chromatography (TLC Silica gel 60, Merck, Darmstadt, Germany) and the biosensor *C*. *violaceum* CV026 ([@ref23]) as described in Ichinose et al. (2020).

Statistical analysis
--------------------

Statistical analysis was performed using One-way ANOVA Dunnett's test and Tukey honestly significant difference test with R software version 3.6.1 (<https://www.r-project.org/>).

Results
=======

Generation of deletion mutants ∆*mexB*, ∆*mexF*, and ∆*mexB*∆*mexF* in *Pta* 6605
---------------------------------------------------------------------------------

The specific deletion of *mexB* and/or *mexF* was confirmed by genomic PCR (data not shown). The growth of each bacterial strain in *in vitro* culture was compared. There was no significant difference in growth speed between the WT strain and the mutant strains ([Fig. 1B](#F1){ref-type="fig"}).

Growth inhibition by plant-derived antimicrobial compounds and antibiotics in WT and mutant strains
---------------------------------------------------------------------------------------------------

Growth inhibition assays of the plant-derived potential antimicrobial compounds in KB soft agar plates showed that 5 µl of 0.9 M trans-cinnamic acid, 0.5 M p-coumaric acid, 1 M acetosyringone, 1 M scopoletin, 1 M chlorogenic acid, 0.3 M phloretin, 1 M naringenin, and 200 mg/ml (+)-catechin did not produce any clear growth inhibition zone in all tested strains (data not shown). Furthermore, 5 µl of 500

µM capsidiol, debneyol, and rishitin, phytoalexins of *Nicotiana tabacum*, *Nicotiana debneyi*, and *Solanum tuberosum*, respectively, also did not inhibit any bacterial growth ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}). When the concentration of capsidiol was increased to 10 mM, no growth inhibition was observed ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}). This concentration of phytoalexins completely inhibits the growth of oomycetes and fungal pathogens ([@ref4]). However, 5 µl of 1 M catechol and 1 M coumarin inhibited the growth of the *Pta* 6605 WT strain ([Fig. 2A and B](#F2){ref-type="fig"}). Furthermore, the size of the growth inhibition zone by 1 M catechol increased in ∆*mexF*, and further expanded in ∆*mexB* and ∆*mexB*∆*mexF*. The ∆*mexB* and ∆*mexB*∆*mexF* mutant strains showed a slightly higher sensitivity than the WT strain to 1 M coumarin; however, the ∆*mexF* mutant produced a smaller inhibition zone than the WT strain. Although 5 µl of 2 M acetovanillone did not inhibit growth of the WT strain, it inhibited those of ∆*mexB* and ∆*mexF*, and an additive growth inhibition effect was observed in the ∆*mexB*∆*mexF* mutant ([Fig. 2C](#F2){ref-type="fig"}).

The sensitivity of bacterial strains to some bacteria-derived antibiotics was also investigated. The sensitivities to most of the antibiotics used in this study, such as kanamycin, spectinomycin, tetracycline, streptomycin, and hygromycin B, did not differ among the bacterial strains (data not shown). However, only ∆*mexB* and ∆*mexB*∆*mexF* were sensitive to 5 µl of 50 mg/ml ampicillin, while the growths of the WT strain and ∆*mexF* were not inhibited by it ([Fig. 2D](#F2){ref-type="fig"}). On the contrary, although the WT and ∆*mexB* mutant strains showed only weak growth inhibition zone to 5 µl of 50 mg/ml chloramphenicol, the growth of ∆*mexF* and ∆*mexB*∆*mexF* mutant strains was remarkably inhibited ([Fig. 2E](#F2){ref-type="fig"}). These results indicate that MexAB-OprM and MexEF-OprN specifically extrude ampicillin and chloramphenicol, respectively.

Gene expression proﬁles of *mexA* and *mexE* in ∆*mexB*, ∆*mexF*, and ∆*mexB*∆*mexF* mutants
--------------------------------------------------------------------------------------------

The effect of the deletion of *mexB*, *mexF*, or both *mexB*/*mexF* on *mexA* and *mexE* gene expression was analyzed by real-time qRT-PCR. As shown in [Fig. 3A](#F3){ref-type="fig"}, the expression of *mexA* was enhanced in the ∆*mexF* and ∆*mexB*∆*mexF* strains. In addition, the expression of *mexE* was very weak, and seemed to be slightly increased in the ∆*mexB* strain ([Fig. 3B](#F3){ref-type="fig"}).

Motility and AHL production in WT and mutant strains
----------------------------------------------------

Surface swimming and swarming motilities of the ∆*mexB* mutant were comparable to WT strain, whereas those of ∆*mexF* and ∆*mexB*∆*mexF* double mutant strains were abolished ([Fig. 4A](#F4){ref-type="fig"}).

*Pta* 6605 utilizes AHLs as quorum-sensing molecules. AHLs production in ∆*mexB* and ∆*mexB*∆*mexF* mutants was reduced. However, the ∆*mexF* mutant retained AHL production ability as good as that of the WT strain ([Fig. 4B](#F4){ref-type="fig"}).

Virulence of WT and mutant strains
----------------------------------

To investigate whether MexAB-OprM and/or MexEF-OprN of *Pta* 6605 is involved in the virulence, a flood inoculation test of the WT, ∆*mexB*, ∆*mexF*, ∆*mexB*∆*mexF*, and ∆*hrcC* mutant strains ([@ref14]) on host tobacco seedlings was performed. The ∆*hrcC* mutant did not show any disease symptoms, and bacterial growth was limited ([Fig. 5](#F5){ref-type="fig"}). On the other hand, all mutants except ∆*hrcC* showed disease symptoms similar to those of the WT strain at 4 dpi ([Fig. 5A](#F5){ref-type="fig"}) and 10 dpi ([Supplementary Fig. 2](#S1){ref-type="supplementary-material"}). However, the bacterial populations in the leaves of ∆*mexB*, ∆*mexF*, and ∆*mexB*∆*mexF* mutant strains were significantly lower than that of WT at 4 dpi ([Fig. 5B](#F5){ref-type="fig"}), indicating that MexAB-OprM and MexEF-OprN might partially contribute to virulence at the early stage of infection.

Discussion
==========

[@ref19] reported that deletion mutants of *mexAB-oprM* of *P*. *syringae* pv. *tomato* DC3000, pv. *phaseolicola* 1448A, and pv. *syringae* B728a exhibited increased susceptibility to bacterial and plant-derived antimicrobials, detergents, and dyes. In this study, we focused on the functions of MexAB-OprM and MexEF-OprN on the plant-derived antimicrobials, phytoanticipins and phytoalexins in *P. syringae* pv. *tabaci*. The increased growth inhibition in ∆*mexB* and ∆*mexB*∆*mexF* of *Pta* 6605 by acetovanillone, catechol, and coumarin indicates that MexAB-OprM may extrude these compounds. [@ref3] reported that tobacco leaves accumulated acetovanillone, acetosyringone, and chlorogenic acid in response to the inoculation of *P. fluorescens*, *P. syringae* pv. *tabaci*, and *P. syringae* pv. *syringae*. Therefore, *Pta* 6605 may extrude these phytoanticipins during infection. Analysis of growth inhibition by formation of growth inhibition zones has the advantage that even hydrophobic substances can be absorbed in a paper disc and their antimicrobial activity examined. However, we did not observe antimicrobial activity in many plant-derived compounds with this method. Therefore, it is possible that some of these compounds might show an inhibitory activity with other methods.

It was reported that the expression of *mexAB*-*oprM* of *P*. *syringae* pv. *tomato* DC3000 increases in the presence of flavonoids such as phloretin and naringenin ([@ref27]). The *mexA* mutant exhibits higher susceptibility to these compounds and caused fewer symptoms compared to the WT strain in the inoculation test on tomato leaves ([@ref27]). Furthermore, the *mexA* mutant bore fewer flagella, and the presence of phloretin reduced the ratio of flagellated cells and swarming motility ([@ref26]). These results indicate that the MexAB-OprM transporter contributes to the colonization on host tomato plants. Although we observed similar swimming and swarming motilities in WT and ∆*mexB* mutant, the mutation of *mexF* resulted in the loss of these motilities, indicating relationship between MexEF-OprN and motility.

An extract of *Arabidopsis thaliana* contains 4-methylsulfinylbutyl isothiocyanate, a natural product derived from aliphatic glucosinolates, which inhibited the growth of non-host *Pseudomonas* bacteria ([@ref5]). In contrast, *P*. *syringae* pathovars like *P. syringae* pv. *tomato* DC3000 that are pathogenic to *A*. *thaliana* can grow with the same extract from *Arabidopsis* because these pathovars have the *sax* ([s]{.ul}urvival in *[A]{.ul}rabidopsis* e[x]{.ul}tract) genes. Parts of the *sax* genes encode MexAB-OprM and MexEF-OprN and confer the ability to extrude a wide range of substrates including antibiotics and host-derived molecules ([@ref5]). The major phytoanticipin varies from plant to plant. Because acetovanillone, catechol, and coumarin inhibit the growth of *Pta* 6605, these compounds may be major phytoanticipins of tobacco, and both MexAB-OprM and MexEF-OprN contribute to the virulence of *Pta* 6605.

As Gnanamanickam and Mansfield (1981) already reported that isoflavonoid (kievitone and phaseollin), flavonoid (hydroxyflavans), furanoacetylenic (wyerone), and sesquiterpenoid (capsidiol and rishitin) phytoalexins do not inhibit the growth of a wide range of bacteria, none of the phytoalexins tested also showed an inhibitory effect on *Pta* 6605 or even ∆*mexB*, ∆*mexF*, and the ∆*mexB*∆*mexF* double mutant ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}). Fifty µg of capsidiol and rishitin did not inhibit the growth of six Gram-positive and eight Gram-negative bacteria including saprophytes and plant and animal pathogens. Camalexin, a phytoalexin in *A. thaliana*, was accumulated in response to the inoculation of *P*. *syringae* pv. *syringae* ([@ref24]). However, a defective mutant that cannot synthesize the camalexin of *A. thaliana* still exhibits resistance to avirulent *P*. *syringae* pathogens, indicating that the accumulation of camalexin is not major defense response to bacterial pathogens ([@ref7]). These mutants displayed enhanced sensitivity to virulent *P*. *syringae* strains, suggesting that camalexin limits the growth of virulent bacteria ([@ref7]).

The *mexEF-oprN* of the WT strain is hardly expressed in the general culture conditions. However, it was weakly activated in the ∆*mexB* mutant. MexEF-OprN might compensate for the lost functionality of MexAB-OprM. MexAB-OprM and MexEF-OprN were expected to extrude acetovanillone, catechol, and coumarin. We will now investigate whether these compounds induce expressions of *mexAB-oprM* and *mexEF-oprN* genes.

The virulence of ∆*mexB*, ∆*mexF*, and ∆*mexB*∆*mexF* was reduced ([Fig. 5](#F5){ref-type="fig"}), and swimming and swarming motilities of ∆*mexF* and ∆*mexB*∆*mexF* was impaired ([Fig. 4A](#F4){ref-type="fig"}). Furthermore, ∆*mexB* and *∆mexB∆mexF* mutants showed reduced production of AHL ([Fig. 4B](#F4){ref-type="fig"}), suggesting that an RND-type multidrug efflux pump transporter not only directly extrudes antimicrobials but also indirectly controls other types of virulence, such as surface motility and the quorum sensing system. This may be the result of environmental adaptation of the mutant strains in the absence of MexAB-OprM or MexEF-OprN.

Electric Supplementary Material
===============================

Supplementary materials are available at The Plant Pathology Journal website (<http://www.ppjonline.org/>).
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![Generation of ∆*mexB* mutant stain and in vitro bacterial growth. (A) Schematic organization of *mexAB-oprM* in *Pseudomonas syringae* pv. *tabaci* 6605. PCR was carried out to isolate and clone the entire region of *mexAB-oprM*. Using pCR-*mexAB-oprM* as a template and mexB-d5NheI and mexB-d3NheI as primers, inverse PCR was carried out to obtain pCR-∆*mexB*. (B) *In vitro* growth of each bacterium. The same density of bacterium (OD~660~ = 0.02) was used to incubate at 27°C with shaking, and bacterial OD~660~ was measured. The bars represent standard deviations for three independent experiments.](PPJ-36-148-f1){#F1}

![Sensitivity of *Pseudomonas syringae* pv. *tabaci* 6605 wild-type (WT) and its mutant strains to several antimicrobial compounds. Growth inhibition on plates with 5 µl of 1 M catechol (A), 1 M coumarin (B), 2 M acetovanillone (C), 50 µg/ml ampicillin (D), and 50 µg/ml chloramphenicol (E). N.D., not detected. Photographs were taken at 24 h after incubation. Data shown below photographs are the averages of three independent replicates of growth-inhibited areas (mm^2^). Statistical groups were determined using Tukey's honestly significant difference test (*P* \< 0.05), and significant differences are indicated by different letters below right of each photograph.](PPJ-36-148-f2){#F2}

![Quantitative reverse transcription PCR analysis of gene expression of *mexA* (A) and *mexE* (B) in wild-type (WT) and mutant strains. Asterisk indicates significant difference from the WT (\*\*\**P* \< 0.001) determined by one-way ANOVA Dunnett's test.](PPJ-36-148-f3){#F3}

![Swarming and swimming motilities and *N*-acyl-homoserine lactone (AHL) production. (A) Surface swarming and swimming motilities after 24 h incubation. (B) AHL production. Ethyl acetate extract from 0.2 ml of each bacterial culture was spotted on the thin layer chromatography plate. AHL was visualized as described in "Materials and Methods".](PPJ-36-148-f4){#F4}

![Inoculation test. (A) Tobacco seedlings were inoculated with wild-type (WT) or *∆hrcC, ∆mexB, ∆mexF, ∆mexB∆mexF*, and ∆*hrcC* strains and incubated at 23°C. Photographs taken 4 days post-infection (dpi) shows representative results. Scale bars = 1 cm. (B) Bacterial populations were determined at 0 or 4 dpi. Box plots and Jitter plots representing the bacterial growth in inoculated plants from three biological replicates. Boxes show the upper and lower quartiles of the data, and horizontal black lines represent the medians. Jitter plots indicate raw data. Statistical significance was determined using one-way ANOVA Dunnett's test where each group was compared with the WT. (\*\**P* \< 0.01, \*\*\**P* \< 0.001). *n* is shown above the stain names.](PPJ-36-148-f5){#F5}

###### 

Bacterial strains and plasmids used in this study

  Bacterial strain or plasmid         Relevant characteristics                                                                                                                    Reference or source
  ----------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- --------------------------
  *Escherichia coli* strain                                                                                                                                                       
  DH5α                                *F^--^*, *λ^--^*, *ø80dLacZ*Δ*M15*, Δ*(lacZYA-argF)*U169, *recA1*, *endA1*, *hsdR17*(r~K~^--^m~K~^+^), *supE44*, *thi-1*, *gyrA*, *relA1*   Takara Bio
  S17-1                               *Thi*, *pro*, *hsdR^-^*, *hsdM^+^*, *recA* \[chr::RP4-2-Tc::Mu-Km::Tn7\]                                                                    [@ref18]
  *Chromobacterium violaceum* CV026   Double mini-Tn*5* mutant from *C. violaceum* ATCC 31532; AHL biosensor, Km^r^                                                               [@ref15]
  *P. syringae* pv. *tabaci*                                                                                                                                                      
  Isolate 6605                        Wild-type, Nal^r^                                                                                                                           [@ref23]
  ∆*hrcC*                             Isolate 6605 *∆hrcC*, Nal^r^                                                                                                                [@ref14]
  ∆mexB                               Isolate 6605 *∆mexB*, Nal^r^                                                                                                                This study
  ∆mexF                               Isolate 6605 *∆mexF*, Nal^r^                                                                                                                [@ref17]
  ∆*mexB*∆*mexF*                      Isolate 6605 *∆mexB*∆*mexF*, Nal^r^                                                                                                         This study
  Plasmid                                                                                                                                                                         
  pCR Blunt II TOPO                   Cloning vector for blunt ended PCR products, Km^r^                                                                                          Thermo Fisher Scientific
  pCR-*mexAB-oprM*                    pCR Blunt II TOPO with 5,789-bp of *mexAB*-*oprM*, Km^r^                                                                                    This study
  pCR-∆*mexB*                         *mexB*-deleted plasmid from pCR-*mexAB-oprM*, Km^r^                                                                                         This study
  pK18*mobsacB*                       Small mobilizable vector, Km^r^, sucrose-sensitive (*sacB*)                                                                                 [@ref18]
  pK18∆*mexB*                         pK18*mobsacB* with *mexA-oprM*, Km^r^                                                                                                       This study

AHL, *N*-acyl-homoserine lactone; Km^r^, kanamycin resistance, Nal^r^, nalidixic acid resistance.

###### 

Oligonucleotide sequences used in this study

  Oligonucleotide name   Sequence (5′-3′)                 Purpose
  ---------------------- -------------------------------- ----------------------------------------------------------------
  mexA5                  TTGAGACAACAGGCTCCTGC             PCR to amplify 5,789 bp of *mexAB-oprM* for cloning
  oprM3                  TCAGAACAGCTGAACCGAAGG            
  mexB-d5NheI            ctagctagcTTACTCCCCTTTGCTGCCTG    Inverse PCR to delete *mexB* coding region to generate ∆*mexB*
  mexB-d3NheI            ctagctagcATGAGCAAGTCATTGATCTCT   
  mexA-F1                CAGGTCAACGGCATCATTCT             qRT-PCR to amplify 168 bp of *mexA* fragment
  mexA-R1                GACCAGTTGCTTGTAGCGATC            
  mexE-F1                CACCTGGGCCAGATGAACTT             qRT-PCR to amplify 203 bp of *mexE* fragment
  mexE-R1                AGCACAAACTTCTTGCCCAG             
  pcaG-F                 TGCAGGAAACCCCTTCGC               qRT-PCR to amplify 113 bp of *pcaG* fragment
  pcaG-R                 GGGCCTGGCCATCTCGTT               

Small letters indicate additive nucleotides containing artificial *Nhe*I sites in mexB-d5NheI and mexB-d3NheI.
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